Accordingly, our previous studies also revealed that CXCL3 facilities the malignant behaviors of tumor cells in cervical cancer and prostate cancer via activation of the MAPK/ERK signaling pathway [10, 11]. The gene discussed is CXCL3; the disease is prostate cancer.